Common Contracts
6 similar Office Lease contracts by Recursion Pharmaceuticals, Inc.
DocuSign Envelope ID: D1F7393F-D384-4DF7-AAO6-1B9C9421 1CDA *During the period from June 1, 2018 through May 31, 2023 (the “Reduced Rent Period”), Tenant shall only be required to pay Base Rent on 88,033 rentable square feet of the Premises (rather...Office Lease • February 27th, 2023 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
DocuSign Envelope ID: Dl F7393F-D384-4DF7-M06-1 B9C9421 1 CDA OFFICE LEASE This Office Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between VESTAR...Office Lease • May 10th, 2022 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
DocuSign Envelope ID: Dl F7393F-D384-4DF7-M06-1 B9C9421 1 CDA OFFICE LEASE This Office Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between VESTAR...Office Lease • March 23rd, 2022 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
DocuSign Envelope ID: Dl F7393F-D384-4DF7-M06-1 B9C9421 1 CDA OFFICE LEASE This Office Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between VESTAR...Office Lease • August 13th, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
OFFICE LEASE VESTAR GATEWAY, LLC, a Delaware limited liability company, as Landlord, and RECURSION PHARMACEUTICALS, INC., a Delaware corporation, as Tenant.Office Lease • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Utah
This Office Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between VESTAR GATEWAY, LLC, a Delaware limited liability company (“Landlord”), and RECURSION PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
OFFICE LEASEOffice Lease • March 3rd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Utah
THIS FIRST AMENDMENT TO LEASE (this “Amendment”) is dated as of September ___, 2018, between VESTAR GATEWAY, LLC, a Delaware limited liability company (“Landlord”), and RECURSION PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
